Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1995-12-12
|
| pubmed:abstractText |
This study was designed to determine the effect of bone resorption on the development of generalized osteopenia in adjuvant-induced arthritic rats. Thirty of a total of sixty male SD rats, 6 weeks of age, were injected with killed mycobacterium butyricum suspended in mineral oil into the right hind paw and assigned to six groups of 5 animals each. The other thirty animals served as the age-matched noninjected controls. Animals were sacrificed at 4, 7, 10, 14, 21, and 28 days post-injection after measuring the bilateral hind-paw volumes. Twenty-four-hour urinary samples were obtained before sacrifice and the levels of deoxypyridinoline (D-Pyr) and creatinine (CR) were measured. Plasma intact osteocalcin levels were measured by a sandwich enzyme immunoassay at the start, 14 and 28 days after injection. Bone mineral measurement and histomorphometrical analyses were performed on specimens of the third lumbar vertebral body. On the seventh day after injection, arthritic rats showed significant decreases in the values of bone mineral content (BMC) and density (BMD) when compared to controls. Urinary D-Pyr/Cr ratios, however, did not increase on the seventh day, showing a significant increase on the tenth day after injection. The serum osteocalcin level was significantly reduced on the fourteenth day. The trabecular bone volume (BV/TV) in the arthritic rats showed a significant decrease from the seventh day. The trabecular thickness (Tb.Th) value significantly decreased on the seventh day after injection.(ABSTRACT TRUNCATED AT 250 WORDS)
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
8756-3282
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
17
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
57-62
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:7577159-Absorptiometry, Photon,
pubmed-meshheading:7577159-Amino Acids,
pubmed-meshheading:7577159-Analysis of Variance,
pubmed-meshheading:7577159-Animals,
pubmed-meshheading:7577159-Arthritis, Experimental,
pubmed-meshheading:7577159-Body Weight,
pubmed-meshheading:7577159-Bone Density,
pubmed-meshheading:7577159-Bone Resorption,
pubmed-meshheading:7577159-Creatinine,
pubmed-meshheading:7577159-Disease Models, Animal,
pubmed-meshheading:7577159-Immunoenzyme Techniques,
pubmed-meshheading:7577159-Linear Models,
pubmed-meshheading:7577159-Lumbar Vertebrae,
pubmed-meshheading:7577159-Male,
pubmed-meshheading:7577159-Mycobacterium,
pubmed-meshheading:7577159-Osteocalcin,
pubmed-meshheading:7577159-Random Allocation,
pubmed-meshheading:7577159-Rats,
pubmed-meshheading:7577159-Rats, Sprague-Dawley
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Changes in urinary deoxypyridinoline level and vertebral bone mass in the development of adjuvant-induced arthritis in rats.
|
| pubmed:affiliation |
Department of Pharmacology, Central Research of Zeria Pharmaceutical Co., Ltd., Saitama, Japan.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|